Junichi Yoshii

3.2k total citations
42 papers, 2.7k citations indexed

About

Junichi Yoshii is a scholar working on Molecular Biology, Hepatology and Cancer Research. According to data from OpenAlex, Junichi Yoshii has authored 42 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 18 papers in Hepatology and 16 papers in Cancer Research. Recurrent topics in Junichi Yoshii's work include Liver physiology and pathology (12 papers), Angiogenesis and VEGF in Cancer (12 papers) and Liver Disease Diagnosis and Treatment (11 papers). Junichi Yoshii is often cited by papers focused on Liver physiology and pathology (12 papers), Angiogenesis and VEGF in Cancer (12 papers) and Liver Disease Diagnosis and Treatment (11 papers). Junichi Yoshii collaborates with scholars based in Japan, Argentina and United States. Junichi Yoshii's co-authors include Hitoshi Yoshiji, Yasuhide Ikenaka, Hiroshi Fukui, Ryuichi Noguchi, Shigeki Kuriyama, Hirohisa Tsujinoue, Koji Yanase, Tadashi Namisaki, Toshiya Nakatani and Mitsuteru Kitade and has published in prestigious journals such as Hepatology, Journal of Hepatology and International Journal of Cancer.

In The Last Decade

Junichi Yoshii

41 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junichi Yoshii Japan 25 1.2k 1.0k 915 523 406 42 2.7k
Yasuhide Ikenaka Japan 27 1.3k 1.1× 1.1k 1.1× 896 1.0× 544 1.0× 452 1.1× 55 2.9k
Mitsuteru Kitade Japan 32 1.2k 1.0× 1.2k 1.2× 1.2k 1.3× 527 1.0× 464 1.1× 88 3.2k
Shinichi Kiso Japan 31 1.0k 0.9× 1.3k 1.3× 1.3k 1.4× 375 0.7× 265 0.7× 84 3.3k
Kosuke Kaji Japan 27 902 0.8× 1.1k 1.1× 786 0.9× 280 0.5× 428 1.1× 126 2.5k
Davide Povero United States 24 740 0.6× 1.3k 1.3× 1.4k 1.5× 727 1.4× 220 0.5× 46 2.7k
Koji Yanase Japan 22 686 0.6× 632 0.6× 479 0.5× 299 0.6× 232 0.6× 38 1.6k
Eitaro Taniguchi Japan 27 1.2k 1.0× 1.1k 1.1× 832 0.9× 341 0.7× 285 0.7× 66 2.9k
Kohichiroh Yasui Japan 41 1.4k 1.2× 2.4k 2.4× 1.8k 2.0× 673 1.3× 962 2.4× 102 4.6k
Masahito Uemura Japan 28 746 0.6× 899 0.9× 335 0.4× 138 0.3× 239 0.6× 66 2.1k
Fouad Lafdil France 25 912 0.8× 1.2k 1.2× 646 0.7× 259 0.5× 216 0.5× 36 2.8k

Countries citing papers authored by Junichi Yoshii

Since Specialization
Citations

This map shows the geographic impact of Junichi Yoshii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junichi Yoshii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junichi Yoshii more than expected).

Fields of papers citing papers by Junichi Yoshii

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junichi Yoshii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junichi Yoshii. The network helps show where Junichi Yoshii may publish in the future.

Co-authorship network of co-authors of Junichi Yoshii

This figure shows the co-authorship network connecting the top 25 collaborators of Junichi Yoshii. A scholar is included among the top collaborators of Junichi Yoshii based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junichi Yoshii. Junichi Yoshii is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaji, Kosuke, Hitoshi Yoshiji, Yasuhide Ikenaka, et al.. (2013). Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats. Journal of Gastroenterology. 49(3). 481–491. 102 indexed citations
2.
Kaji, Kosuke, Hitoshi Yoshiji, Mitsuteru Kitade, et al.. (2010). Selective aldosterone blocker, eplerenone, attenuates hepatocellular carcinoma growth and angiogenesis in mice. Hepatology Research. 40(5). 540–549. 18 indexed citations
3.
Yoshiji, Hitoshi, Ryuichi Noguchi, Mitsuteru Kitade, et al.. (2009). Branched-chain amino acids suppress insulin-resistance-based hepatocarcinogenesis in obese diabetic rats. Journal of Gastroenterology. 44(5). 483–491. 54 indexed citations
4.
Yoshiji, Hitoshi, Ryuichi Noguchi, Yasuhide Ikenaka, et al.. (2009). Losartan, an angiotensin-II type 1 receptor blocker, attenuates the liver fibrosis development of non-alcoholic steatohepatitis in the rat. BMC Research Notes. 2(1). 70–70. 47 indexed citations
5.
Kitade, Mitsuteru, Hitoshi Yoshiji, Hideyuki Kojima, et al.. (2006). Leptin‐mediated neovascularization is a prerequisite for progression of nonalcoholic steatohepatitis in rats†. Hepatology. 44(4). 983–991. 122 indexed citations
6.
Yoshiji, Hitoshi, Shigeki Kuriyama, Ryuichi Noguchi, et al.. (2005). Combination of vitamin K2 and the angiotensin-converting enzyme inhibitor, perindopril, attenuates the liver enzyme-altered preneoplastic lesions in rats via angiogenesis suppression. Journal of Hepatology. 42(5). 687–693. 57 indexed citations
7.
Yoshiji, Hitoshi, Shigeki Kuriyama, Ryuichi Noguchi, et al.. (2005). Combination of interferon‐β and angiotensin‐converting enzyme inhibitor, perindopril, attenuates the murine liver fibrosis development. Liver International. 25(1). 153–161. 21 indexed citations
8.
Yoshiji, Hitoshi, Shigeki Kuriyama, Junichi Yoshii, et al.. (2004). Halting the interaction between vascular endothelial growth factor and its receptors attenuates liver carcinogenesis in mice. Hepatology. 39(6). 1517–1524. 85 indexed citations
9.
Yoshiji, Hitoshi, Ryuichi Noguchi, Shigeki Kuriyama, et al.. (2004). Imatinib mesylate (STI-571) attenuates liver fibrosis development in rats. American Journal of Physiology-Gastrointestinal and Liver Physiology. 288(5). G907–G913. 124 indexed citations
10.
Yoshiji, Hitoshi, Shigeki Kuriyama, Junichi Yoshii, et al.. (2004). Involvement of the vascular endothelial growth factor receptor-1 in murine hepatocellular carcinoma development. Journal of Hepatology. 41(1). 97–103. 26 indexed citations
11.
Yoshiji, Hitoshi, Shigeki Kuriyama, Junichi Yoshii, et al.. (2002). Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma. Hepatology. 35(4). 834–842. 126 indexed citations
12.
Yoshiji, Hitoshi, Junichi Yoshii, Yasuhide Ikenaka, et al.. (2002). Inhibition of renin–angiotensin system attenuates liver enzyme-altered preneoplastic lesions and fibrosis development in rats. Journal of Hepatology. 37(1). 22–30. 81 indexed citations
13.
Yoshiji, Hitoshi, Shigeki Kuriyama, Junichi Yoshii, et al.. (2002). Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse. Hepatology. 36(4). 850–860. 191 indexed citations
14.
Yoshiji, Hitoshi, Shigeki Kuriyama, Junichi Yoshii, et al.. (2001). Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology. 34(4). 745–750. 334 indexed citations
15.
Yoshiji, Hitoshi, Shigeki Kuriyama, Daniel J. Hicklin, et al.. (2001). The Vascular Endothelial Growth Factor Receptor Kdr/Flk–1 Is A Major Regulator of Malignant Ascites Formation in the Mouse Hepatocellular Carcinoma Model. Hepatology. 33(4). 841–847. 49 indexed citations
16.
Tsujimoto, Tatsuhiro, Shigeki Kuriyama, Masahide Yoshikawa, et al.. (2000). A CASE OF PEMPHIGUS VULGARIS INVOLVING THE EISOPHAGUS. Acta gastro-enterologica belgica. 42(1). 20–26. 2 indexed citations
17.
Yoshiji, Hitoshi, Shigeki Kuriyama, Yoji Miyamoto, et al.. (2000). Tissue Inhibitor of Metalloproteinases–1 Promotes Liver Fibrosis Development in A Transgenic Mouse Model. Hepatology. 32(6). 1248–1254. 221 indexed citations
18.
Yoshiji, Hitoshi, Shigeki Kuriyama, Daniel J. Hicklin, et al.. (1999). KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells. Hepatology. 30(5). 1179–1186. 84 indexed citations
19.
Yoshiji, Hitoshi, Shigeki Kuriyama, Junichi Yoshii, et al.. (1998). Vascular Endothelial Growth Factor Tightly Regulates In Vivo Development of Murine Hepatocellular Carcinoma Cells. Hepatology. 28(6). 1489–1496. 91 indexed citations
20.
Yoshii, Junichi, et al.. (1994). An Expression Profile of Active Genes in Human Colonic Mucosa. DNA Research. 1(1). 37–45. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasuhide Ikenaka Breakdown of academic impact, for papers by Mitsuteru Kitade Breakdown of academic impact, for papers by Shinichi Kiso Breakdown of academic impact, for papers by Kosuke Kaji Breakdown of academic impact, for papers by Davide Povero Breakdown of academic impact, for papers by Koji Yanase Breakdown of academic impact, for papers by Eitaro Taniguchi Breakdown of academic impact, for papers by Kohichiroh Yasui Breakdown of academic impact, for papers by Masahito Uemura Breakdown of academic impact, for papers by Fouad Lafdil
Rankless by CCL
2026